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Introduction: Angiogenesis is the process of forming new capillaries from existing ones. This 
process is important for tumor growth and metastasis. It is also important during wound healing. 
During tumor metastasis this process is amplified, as new capillaries are needed for cancer to 
spread, but in ulcerations, when this process does not occur, ulceration does not heal. 
Cyclooxygenase-2 (COX-2), nitric oxide synthase (NOS) and lipoxygenase (LOX) are some of 
the enzymes that are highly expressed during angiogenesis and therefore provide a useful way 
to detect angiogenesis. Some medicinal plants have been shown to possess angiogenetic 
modulating properties, which has led to the development of anti-angiogenic drugs. Euphorbia 
tirucalli, Spirostachys Africana sond, and Synadenium cupulare (Boiss.) L.C. have traditionally 
been used for treatment of open wounds, ulcers and cancer. Their mechanism(s) of action is, 
however, still not clear. These plants have therefore been selected to determine their effect on 
angiogenesis, as angiogenesis is a denominator for cancer and tissue regeneration, which is 
critical for wound healing and healing of ulcers.  
Aim: The study aims to evaluate the effects of selected medicinal plants for their angiogenesis 
modulating effects by determining their inhibitory effects on COX-2, LOX and NOS enzymes, as 
well as their growth inhibitory effects on MCF-7 cells.  
Methods: The plants were collected from their natural habitat in Pretoria and the Kruger 
National Park, Limpopo. Plants were dried and extractions were made with water and 
sequentially with hexane, dichloromethane, methanol and ethyl acetate. Phytochemical analysis 
was performed to determine the classes of compounds present in the plants. The MCF-7 cells 
were cultured in DMEM and 10% fetal bovine serum  under normal culture conditions. The cells 
were treated with different concentrations of the plant extracts. After exposure, the cell viability 
was measured using MTT assay. The cell lysate was then evaluated for enzymatic activity of 
COX-2 and LOX. Pure enzymes obtained commercially were used as positive controls, while 
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commercial substrates were used for standard curves using enzyme.  The culture media were 
tested for the amount of nitric oxide produced by cells after incubation with extracts. 
Results and discussion: The plant ingredients were extracted successfully and the yields were 
recorded. Phytochemical analysis revealed the presence of tannins, saponins and glycosides on 
all plants. Euphorbia tirucalli was one of the plants that had the lowest number of 
phytochemicals, namely saponins, glycosides, tannins and triterpenoids. This plant also had the 
lowest cell growth inhibitory activity around 10 μg/ml or higher and the lowest enzyme inhibitory 
activity. Spirostachys africana had most phytochemicals and the highest growth inhibition of 
MCF-7 cells with IC50 around 1 μg/ml and selectivity for cancer cells over MCF-10A and CHO 
cells. E. cupularis had the second highest number of phytochemicals and also exhibited good 
cell growth inhibition, ranging around 5 to 1 μg/ml, and good selectivity for cancer cells, 
especially the nonpolar extracts. The extracts induced NOS, which is indicative of apoptosis or 
which could imply induction of apoptosis by activating inducible NOS. Selective extracts of E. 
cupularis and S. africana might inhibit angiogenesis through cyclooxygenase inhibition. LOX 
inhibitory activity was concentration-dependent. The highest extract concentration had the 
highest inhibitory activity.  
Conclusion: From our findings, we suggest that non-polar extracts of S. africana and E. 
cupularis have anti-cancer activity and anti-angiogenic activity as well. Our results were also 
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Angiogenesis is the processes of forming new capillary vessels from existing ones. It is 
a normal biological process that occurs during the female reproductive cycle, wound 
healing and treatment of ulcers (Nishida et al, 2006). Studies have shown that abnormal 
angiogenesis is related to tumor growth and progression to a metastatic phenotype 
(Folkman, 1971). Metastasis refers to the spreading of neoplasm to other tissues or 
organs and for this to occur, new vessels are required to supply the tumor with nutrients 
and oxygen (Nishida et al, 2006). Angiogenesis is a complex process that involves 
growth factors, cytokines and enzymes such as cyclooxygenases (COX), nitric oxide 
synthase (NOS) and lipoxygenase (LOX). These three enzymes, in particular, have 
been selected as the focus of the study, because of their significant role in angiogenesis 
and their implication in tumor initiation and growth.  
Cyclooxygenases are the enzymes that catalyze the oxidation of a wide variety of 
xenobiotics, including prostaglandin (Smith et al, 1991). There are two forms of COX: 
COX1- and COX-2. COX-1 is constitutive, is found in most tissues and maintains 
homeostasis, while COX-2 is inducible and functions in inflammation and tumor 
angiogenesis (Sano et al, 1995; Kujubu et al, 1993). 
Lipoxygenases are a group of enzymes with a non-heme iron atom that catalyze the 
oxidation of poly-unsaturated fatty acids such as arachidonic acid (Wisastra & Dekker, 
2014). They are classified as 5-, 8-, 12- and 15-LOX according to their preferred 
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oxidation position on the fatty acids (Brash, 1999). Expression of 12-LOX in prostate 
cancer induced tumor angiogenesis (Nie et al, 1998). 
Nitric oxide (NO) was initially described as an endothelium-derived relaxing factor with 
vasomotor regulatory effect by Furchgott and Zawadzki in 1980. Further investigation of 
this molecule led to the discovery of more regulatory effects, such as smooth muscle 
proliferation, inhibition of platelet activation and inhibition of leukocyte function (Schmidt 
& Walter, 1994). NOS forms NO from L-arginine. Higher levels of inducible NOS were 
detected in metastatic tumors than in benign tumors (Cianchi et al, 2003). 
Medicinal plants are widely used in South Africa, especially in rural areas where there is 
a lack of good health care services. Most rural people choose medicinal plants over 
western medicine because medicinal plants are affordable and accessible. Spirostachys 
Africana Sond, Synadenium cupulare (Boiss.) L.C. and Euphorbia tirucalli are some of 
the medicinal plants that have traditionally been used for the treatment of ulcers and 
open wounds, which are the processes that require angiogenesis. Gastrointestinal 
ulcers are caused by a shearing of the stomach lining. Wounds and ulceration require 
angiogenesis to be healed, so that new vesicles are produced at the healing site, to 
supply oxygen and nutrients (DiPietro, 2016). These plants have also been used 
traditionally for the treatment of various cancers. These two disease conditions share 
the process of angiogenesis, where a shift in balance of angiogenesis can result in 
either tumor initiation or wound healing. 
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1.1 Problem statement 
Angiogenesis is important for tumor metastasis and wound healing, as new capillaries 
are required for delivery of nutrients and oxygen as well as removal of metabolic waste. 
Drugs used in the treatment of cancer have adverse side effects such as hair loss, 
ulcers and damage to the reproductive system (Redd et al, 2001). Therefore there is a 
need for better and efficient drugs that target and eradicate cancer cells only. Medicinal 
plants have been used for generations, proving that they are safe to consume. 
Moreover, there is still much scientific knowledge to be discovered from these plants. 
Angiogenesis is a complex process with multiple pathways, which makes it difficult to 
inhibit this process in tumor metastasis. Medicinal plants may provide different 
pathways through which they exert inhibition on this process.    
 
1.2 Hypothesis 
One of the ways to inhibit tumor angiogenesis is to inhibit the enzymes that regulate 
these pathways; these include COX-2, LOX and NOS. The three enzymes stimulate 
angiogenesis in different pathways. The effects of selected plants on different biological 
targets would give an indication of their mode of action. MCF-7 cells are derived from 
metastatic breast cancer cells, have ideal tumor characteristics and have been chosen 
as the in vitro model to study anti-proliferation and inhibition of enzymes involved in 
tumor angiogenesis. 
 




The aim of the study is to evaluate the effects of the selected medicinal plants for their 
angiogenesis modulating effects on the growth of MCF-7 cells and by determining their 
inhibitory effects on COX-2, LOX and NOS enzymes, which are highly implicated in the 
process of angiogenesis. 
 
1.4 Objectives 
 To collect selected plants, extract substances from the plants, and screen the 
extracts for their proliferative or anti-proliferative effect on breast cancer MCF-7 
cells 
 To determine the selectivity effects of the extracts on normal breast MCF-10A 
cells and CHO cells 
 To determine the effects of the extracts on the enzymatic activity of COX-2, NOS 
and LOX in MCF-7 cells  
 To perform phytochemical analysis of the plants to identify the classes of 
secondary metabolites present. 
  




2. LITERATURE REVIEW 
2.1 Angiogenesis 
Angiogenesis has been the focus of study ever since Judah Folkman (1971) found out 
that it promotes tumor progression to a metastatic phenotype. Therefore much research 
has been done on angiogenesis since the 1980s and many regulatory factors have 
been identified (Otrock et al, 2007). Angiogenesis occurs from early embryonic 
development to adulthood and if it is not properly regulated, especially in adults, it 
results in the development of tumors. There are a number of diseases that result from 
abnormal angiogenesis, which include cancer, diabetic retinopathy, rheumatoid arthritis 
and cardiovascular disorders (Pandya et al, 2006). 
Angiogenesis is controlled by a balance between angiogenic and angiostatic growth 
factors (Toomey et al, 2009). When more angiogenic growth factors are activated, the 
balance tips off to the side of angiogenesis; this is called the ‘angiogenic switch’ and it 
occurs owing to inflammation, neoplasia or hypoxia (McMahon, 2000). When the 
‘angiogenic switch’ is turned on, growth factors bind to specific receptors on endothelial 
cells, causing the endothelial cells to proliferate and migrate out of existing vessels. 
Adhesion molecules or integrins help pull the new vessels outwards, while matrix 
metalloproteinases dissolve the tissue in front of the sprouting vessels. Tissues then 
form around new vessels and the blood begins to flow (figure 1) (Pandya et al, 2006). 




Figure 1. The process of angiogenesis (Pandya et al, 2006). 
.  
2.2 Tumor angiogenesis 
Angiogenesis is important for the growth of tumors and metastasis (Pandya et al, 2006). 
This has been proven by a study conducted by Muthukkaruppan et al (1982) when they 
compared the behavior of cancer in different regions of the same cells. It was found that 
cancer cells placed in a region where angiogenesis was possible grew more than the 
cells placed where angiogenesis did not occur (Muthukkaruppan et al, 1982). The 
relationship between angiogenesis and tumor metastasis was first described by 
Folkman and coworkers in the 1971. It was showed that tumor development is 
dependent on neovascularization and suggested that this involves growth factors 
released during angiogenesis. 
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The development of a tumor is a multi-stage process (Parangi et al, 1996). 
Tumorgenesis occurs in two stages; the first step is a switch from dormancy to 
hyperproliferation of the oncogene expressing pancreatic f3 cells associated with 
activation of the expression of insulin-like growth factor II (IGF-II) (Christofori et al, 
1994). The second step is the activation of angiogenesis, where new capillaries are 
formed from existing ones (figure 2). 
 
 
Figure 2. Schematic presentation that shows the multi-stage development of a tumor (Christofori 
et al, 1994)  
Evidence that tumor metastasis is dependent on angiogenesis has been shown in many 
research projects. This hypothesis, however, does not include the early development of 
solid tumors when the cells are about 1016 (Folkman, 1990). Tannock (1970) estimated 
the kinetic parameters for endothelial cells of capillary walls, fibroblasts and carcinoma 
cells of transplanted C3H mouse mammary cells. He found that the labeling index, 
mitotic index and mean grain count per labeled cells decreased with increased distance 
of the carcinoma cells from the capillaries (Tannock, 1970). Folkman and coworkers 
(1966) compared tumors grown in isolated perfused organs and found that tumors 
grown where blood vessels did not proliferate were growth-limited but grew rapidly after 
vascularization when they were implanted into mice (Folkman et al, 1966). When 
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Gimbrone et al (1972) implanted anaplastic Brown Pearce carcinoma into the iris of 
rabbits, the cells always vascularized, and when they were implanted far from the iris, 
they did not vascularize and remained small and mitotically active. However, when the 
same cells were placed in the iris, they grew and became invasive. This suggests that if 
tumor angiogenesis is blocked, tumors will be growth-restricted, non-invasive and non-
lethal.  
 
Tumor angiogenesis is a complicated process in that it has a number of signaling 
pathways (figure 3).One of the ways to inhibit tumor angiogenesis is to inhibit the 
enzymes that regulate these pathways; these include COX-2, LOX and NOS. These 
enzymes are discussed in detail below.  
 
 
Figure 3. Signaling pathways of tumor angiogenesis (Bhat and Singh, 2008) 
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2.3 Angiogenesis and ulcerations 
Ulcerations are open wounds that fail to heal and like regular wounds, they contain 
inflammatory cells, granulation tissue, exposed collagen and necrotic debris (Folkman 
et al, 1991). They also lack an epithelial covering and the granulation tissue is made up 
of capillary blood vessels, monocytes and fibroblasts. Folkman et al (1991) 
administered basic fibroblast growth factor (bFGF-C523) to rats with duodenal ulcers for 
21 days and this stimulated an over nine-fold increase in angiogenesis and accelerated 
healing. 
Non-steroidal anti-inflammatory drugs (NSAIDS) have been used to treat cancer, but 
the continued used of these drugs increases the occurrence and delayed healing of 
gastroduodenal ulcers (Hawkey, 1990). These drugs function by non-selectively 
inhibiting angiogenesis, a process that plays a key role in healing ulcers by stimulating 
granulation tissue maturation (Tarnawski et al, 1991; McGrath, 1985). 
Gangrene is a skin ulcer that is resistant to common treatments (Asai et al, 2006). It 
occurs mostly in people with diabetes mellitus, a disease that causes microvascular 
disorders and an immunocompromised state that leads to gangrene (Asai et al, 2006). 
A study on genetically diabetic mice with gangrene showed that the healing site had 
reduced infiltration of monocytes and macrophages, as well as keratinocyte growth 
factor expression and vascular endothelial factor, which are increased in normal wound 
healing (Werner et al, 1994). In another study, Asai et al (2006) treated a 65-year-old 
man who had aggressive diabetic gangrene on his left foot with peripheral blood 
mononuclear cells and bFGF. The ulcer closed completely and no new ulcerations were 
observed thereafter.  
© Central University of Technology, Free State
19 
 
NSAIDS cause ulcers because they block angiogenesis completely, therefore there is a 
need for selective inhibitors that will not block regulatory angiogenesis that maintains 
homeostasis ulcers (Hawkey, 1990). In order for gastroduodenal ulcers and gangrene to 
heal, angiogenesis must take place at the healing site. Gangrene is normally treated by 
excising the affected site; however, this does not always stop the disease (Asai et al, 
2006). Therefore there is a need for better treatment of gangrene in the form of 
angiogenesis activators at the healing site.  
2.4 Cyclooxygenase 2 
COXs catalyse the conversion of arachidonic acid to prostaglandins (Menczer, 2009). 
The enzyme has two catalytic sites: the COX site, which converts arachidonic acid to 
endoperoxide PGG2, and the peroxidase site, which converts PGG2 to PGH2 (Botting, 
2006). There are two forms of COX: COX-1 is constitutive, is found in most tissues and 
maintains homeostatis, while COX-2 is inducible and functions in inflammation and 
tumor angiogenesis (Sano et al, 1995; Kujubu et al, 1993). 
COXs produce prostaglandin PGG2, which has been found to be higher in human colon 
tumor than in normal cells (Bennet, 1987). Furthermore, Sano et al (1995), showed that 
immunoreactive COX-2 was expressed in colorectal cancer cells, inflammatory 
mononuclear cells, vascular endothelial cells and fibroblasts, but immunoreactive COX-
1 was expressed in extremely low amounts when histochemical analysis was 
performed. This indicates that COX-2, but not COX-1, is involved in abnormal 
angiogenesis, which leads to the progression of metastatic tumors.  
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Prostaglandins produced by COX-2 bind receptors and activate signaling pathways that 
control proliferation, invasion and angiogenesis of tumors (Wang & DuBois, 2006). 
Chang et al (2004) found that endomethacin, a COX-2 inhibitor, inhibited up-regulation 
of angiogenic regulatory genes, suggesting that prostaglandins release by COX-2 
induce angiogenesis. 
Gallo et al (2001) found elevated levels of prostaglandin E2 in tumor front zone 
compared to normal mucosa and a significant correlation between COX-2 expression 
and tumor vascularization, microvessel density and VEGF expression in head and neck 
cancer. Huang et al (2005) found the same results in gastric carcinoma, which means 
that COX-2 and VEGF are both involved in the same pathway to activate tumor 
angiogenesis.  
 
Figure 4. A Schematic presentation of the role of COX-2 in controlling proliferation, invasion, apoptosis and 
tumor angiogenesis (Toomey et al 2009). 




LOXs catalyze the oxidation of arachidonic acid (Wisastra & Dekker, 2014). LOXs are 
classified as 5-, 8-, 12- and 15-LOX, according to their preferred oxidation position on 
the fatty acids (Brash, 1999), and of these, the platelet type 12-LOX and 5-LOX are 
involved in tumor angiogenesis. Gao et al (1995) found elevated levels of platelet-type 
12-LOX messenger ribonucleic acid (mRNA) in the metastatic prostate tumor cells. This 
led Nie et al (1998) to investigate the effects of this LOX further. They found that it 
stimulates tumor angiogenesis in prostate adenocarcinoma cells.  
In 2000, Nie et al found that N-benzyl-N-hydroxy-5-phenylpentanamide (BHPP), a 12-
LOX inhibitor, reduced endothelial cell proliferation, migration and the formation of tube-
like structures in the Matrigel. These processes where stimulated by vascular 
endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF); 
overexpression of 12-LOX stimulates endothelial cell migration and tube differentiation 
(Nie et al, 2000). VEGF and bFGF induce tumor angiogenesis. This therefore proves 
that 12-LOX is involved in the same pathways as these growth factors to induce 
angiogenesis.  
Another LOX has been implicated in the development of tumors. Boado et al (1992) 
found more abundant 5-LOX transcripts in brain tumors than in normal bovine brain. 
Avis et al (2001) exposed breast cancer cells to 5(S)-hydrooxyeicosa-6E,8C,11Z,14Z-
tetraenoic acid (5-HETE), a product of 5-LOX, and found that this process stimulated 
growth, but when they added a 5-LOX selective inhibitor, growth was reduced and 
apoptosis increased. Gupta et al (2001) found higher levels of 5-LOX mRNA, up-
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regulation of 5-LOX and higher levels of 5-HETE in prostate malignant tissue than in 
normal prostate tissue.     
2.6 Nitric oxide synthase 
NO is synthesized by NOS isoenzymes. These isoenzymes form NO from L-arginine 
with L-citrulline as the coproduct (Iyengar et al, 1987), and of these isoenzymes, 
endothelial NOS is involved in angiogenesis (Papapetropoulos et al, 1997). Gallo et al 
(1998) assessed the role of NO in angiogenesis and found that the levels of NOS were 
higher in tumor than in normal mucosa and that blocking NO production decreases 
tumor angiogenesis. 
Cianchi et al (2003) found elevated levels of inducible nitric oxide synthase (iNOS) and 
VEGF in colorectal cancer, and higher activity of iNOS in metastatic tumors than in non-
metastatic ones. Jadeski and Lala (1999) treated metastatic murine mammary 
adenocarcinoma cells with an iNOS inhibitor called L-NAME (N-nitro-L-arginine methyl 
ester) and it reduced tumor-induced neovascularization. Ziche et al (1997) found that L-
NAME blocked VEGF-induced angiogenesis but not bFGF-induced angiogenesis in 
rabbits bearing corneal implants transfected with MCF-7 breast cancer cells. 
Furthermore, NOS and guanylate cyclase inhibitors blocked post-capillary endothelial 
cell migration and VEGF-induced growth, suggesting that VEGF and bFGF are involved 








3. MEDICINAL PLANTS 
Long before the birth of western medicine, plants were the only source of medicine. 
Plants were used to treat many kinds of diseases. The most common use was to apply 
a decoction to open wounds to prevent microbial infection (Rios & Recio, 2005). Most of 
the pharmaceutical drugs used today are also derived from medicinal plants and over 
80% of the world population still use medicinal plants (Kamboj, 2000) to treat various 
ailments. Medicinal plants are in demand in both developing and developed countries 
because of their safety, efficiency and lower side effects, in addition to the fact that they 
have been tried and tested for generations.  
Spirostachys Africana Sond, Synadenium cupulare (Boiss.) L.C. and Euphorbia tirucalli 
are some of the medicinal plants that have traditionally been used for the treatment of 
ulcers, open wounds and cancer. 
 
3.1. Spirostachys Africana Sond 
Spirostachys Africana Sond, which is also known as tamboti, is a member of the family 
Euphorbiaceae. This plant species is found all over Southern Africa and Central Africa 
(Palgrave, 1990). In South Africa, the stem and bark is used to treat stomach pain, 
stomach ulcers, kidney complaints and cough and eye complaints (Mabogo, 1990; 
Cocks & Dolds, 2000; McGaw et al, 2000; Verschaeve et al, 2004; Mathabe et al, 
2006). Crude extracts from the bark have antibacterial activity against bacteria that 
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cause diarrhea (Mathabe et al, 2006). However no studies have been done on its 
ethnomedicinal usage to treat ulcers. The processes of healing ulcers require 
angiogenesis. 
 
Figure 5. Picture of Spirostachys Africana Sond (https://za.pinterest.com/mackboshoff/indigenous-sa-trees) 
 
3.2. Synadenium cupulare (Boiss.) L.C. 
Synadenium cupulare (Boiss.) L.C., also known as Euphorbia cupularis, belongs to the 
Euphorbiacea as well. It is found in South Africa and Mozambique. In South Africa, the 
dried leaves are used to treat headaches and flu. The latex is used to treat toothaches 
by placing it on a tooth cavity, and to treat infected wounds. The ethanolic leaf extract 
has been found to inhibit prostaglandin synthesis by inhibiting COX (Jager et al, 1996). 
Prostaglandins are mediated in inflammation pain sensation. 




Figure 6. Euphorbia cupularis (http://www.ethnopharmacologia.org/recherche-dans-prelude/?plant_id=5738) 
 
3.3 Euphorbia tirucalli  
Euphorbia tirucalli, known as the pencil tree because of its pencil-like branches, is an 
evergreen succulent plant that grows up to 10 meters (Van Damme, 2001). This plant is 
so widely spread throughout the tropical regions of the world that its origin is unknown; 
however, some speculate that it originated from East Africa. It is endemic in Angola, 
Senegal, Ethiopia, Malawi, Zanzibar, Eritrea, Sudan, Rwanda, Uganda and Tanzania 
(Van Damme, 1989; Schmelzer & Gurib-Fakim, 2008). The plant has many medicinal 
uses in different parts of the world, of which some are the same. 
In East Africa, the plant’s latex is used to cure sexually transmitted infections, epilepsy, 
toothache, snake bites and hemorrhoids (Van Damme, 1989). In Malaysia, a poultice of 
the roots and stem is applied to nose ulcerations, hemorrhoids and swelling, while in 
Brazil, it used against cancer, sarcomas, chancroids, tumors and warts (Duke, 1983).  




Figure 7. Image of Euphorbia tirucalli (https://kumbulanursery.co.za/plants/euphorbia-tirucalli-cultivar-rosea) 
The latex protects the plant from herbivores, as it is an irritant. It contains compounds 
such as phorbol esters, triterpenes, polyphenols and steroids (Mwine & Van Damme, 
2011). The acetone extract of this plant’s latex contains tumor-promoting compounds 
(Roe & Peirce, 1961). These findings conflict with the anti-cancer use of this plant by 
the Brazilans; however, the E. tirucalli used in the particular research project was not 
from Brazil, and Kinghorn (1979) found a compound in the latex of a Colombian E. 
tirucalli that was not present in the South African E. tirucalli. Fürstenberger and Hecker 
(1985) isolated the irritant and tumor-promoting compounds in the latex of a South 
African E. tirucalli and identified them as ingenane and tigliane type diterpene esters, as 
well as 4-deoxyphorbol, phorbol and ingenol.  
Lin et al (2012) isolated euphol from the methanol extract of E. tirucalli found in Taiwan 
and found that this compound inhibits human gastric cancer cell growth by inducing 
ERK1/2-mediated apoptosis. This introduces the question whether the plant is 
carcinogenic or cures cancer. The literature points to both, and that similar species of E. 
tirucalli growing in different places have different latex compositions.  
 




4. MATERIALS AND METHODS 
4.1. Plant collection and extraction 
Plants were collected from their natural habitat in Pretoria and the Kruger National Park, 
Limpopo Province, South Africa during late summer and early autumn. The plants were 
washed with tap water, dried at room temperature and ground to a fine powder. A 
portion of the ground plant material was extracted with water (40 g/L) twice for 24 hours 
and another portion was extracted (40 g/L) sequentially with hexane, dichloromethane 
(DCM), DCM:MeOH (1:1 ratio), Methanol (MeOH) and ethyl acetate. The organic 
solvent filtrate was concentrated with a rotary evaporator (Buchi rotavapor R-100), while 
the water extract was dried using freeze dryer (Dura-Dry microprocessor) Percentage 
yield was calculated using this formula:  
%yield= mass of extract/mass of powder 
4.2 Phytochemical analysis 
Phytochemicals studies of the powdered plant parts were carried out using colorimetric 
assays described by Yadav & Agarwala, 2011.  
Determination of phytosterols 
The powered plant material was weighed to yield 0.05 g. To the powdered material, 
10 ml of chloroform was added, then 1 ml of concentrated H2SO4 was added with 
caution down the side of the test tube to 0.5 ml of chloroform extract. The appearance 
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of a reddish brown color in the chloroform layer was indicative of the presence of 
phytosterols. 
Determination of pentose 
Forty milliliters (40 ml) of distilled water was added to 2 g of powdered plant material. 
The mixture was then filtered. To the 2 ml filtrate, 2 ml of hydrochloric acid containing a 
little phloroglucinol was added. The mixture was then heated for five minutes. The 
formation of a red color was indicative of the presence of pentose. 
Determination of tannins 
Twenty milliliters (20 ml) of distilled water was added to 0.5 g of powdered plant 
material. The mixture was then boiled and filtered while it was still hot. The filtrate was 
treated with three drops of 0.1% of ferric chloride. A blue-black precipitate was 
indicative of the presence of tannins. 
Determination of glycosides 
Two milliliters (2 ml) of acetic acid was added to 0.5 g of powdered plant material. The 
mixture was then treated with one drop of 0.1% of ferric chloride, after which 1 ml of 
concentrated sulfuric acid was added to the mixture with caution. The appearance of a 
brown ring was indicative of the presence of deoxy sugars. 
Determination of triterpenoids 
One milliliter (1 ml) of chloroform was added to 2 mg of powdered plant material, then 3 
ml of concentrated sulfuric acid was  added to the mixture with caution. The formation of 
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an interface with reddish brown coloration was indicative of the presence of 
triterpenoids. 
Determination of anthroquines 
Twelve milliliters (12 ml) of 10% HCl solution was added to 1 g of powdered plant 
material and boiled for five minutes. The mixture was filtered and left to cool before 10 
ml of chloroform was added to the filtrate. The chloroform layer was then placed in a 
clean test tube and 10 ml of 10% ammonia solution was added to this mixture. The 
mixture was shaken and the formation of a rose pink color in the top layer was indicative 
of anthroquines. 
Determination of saponins 
Five milliliters (5 ml) of distilled water was added to 0.5 g of powdered plant material, 
boiled and filtered, then 3 ml of distilled water was added to the filtrate. The mixture was 
shaken vigorously for five minutes. Frosting indicated the presence of saponins. 
Determination of flavonoids 
Ten milliliters (10 ml) of ethyl acetate was added to 0.5 g of powdered plant material 
and heated for three minutes, allowed to cool and then filtered, before 1 ml of dilute 
ammonia solution was added to 5 ml of the filtrate. The mixture was shaken. A yellow 
precipitate was indicative of the presence of flavonoids. 
Determination of alkaloids 
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Two milliliters (2 ml) of 1% HCl was added to 0.2 g of powdered plant material and 1 ml 
of Meyer’s reagent was added to the mixture, followed by 1 ml of Drangendorff reagent. 
The appearance of an organic precipitate indicated the presence of alkaloids. 
 
4.3 Cell culturing 
4.3.1 Cell culture conditions 
 
The culture environment was maintained at 37°C in a humidified, concentrated CO2 
(5%) atmosphere. The cells were grown in DMEM media (Sigma, South Africa) 
supplemented with 10% FBS until 80% confluent. 
 
4.3.2 Cell trypsinization and sub-culturing 
Once MCF-7 cells had reached approximately 80% confluency in the flask, which was 
confirmed by microscopic analysis, they were trypsinized. Cells were rinsed with 10 ml 
of sodium phosphate buffer (PBS). Aliquots of 2 ml of warm (37°C) trypsin-EDTA 
solution were added for two minutes to detach the cells. After two minutes, the cells 
were checked for detachment under a microscope, then trypsin-EDTA was neutralized 
by adding equal amounts of complete medium. The cell suspension was centrifuged at 
700 rpm for five minutes to obtain a cell pellet. The cell pellet (MCF-7 cells) was re-
suspended in 4 ml fresh growth medium. An aliquot of 20 µl was removed for cell 
counting, to determine cell viability. The amount of cell suspension to be added to 10 ml 
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of complete medium to obtain a cell concentration of 1x105 cells/ml was calculated and 
added; thereafter the cells were plated in a 96-well plate and incubated at 37°C in a 
humidified 5% CO2 atmosphere. 
4.3.3 Cell viability count 
Cell viability was determined using trypan blue staining solution: 20 µl of cell suspension 
was mixed with 20 µl of trypan blue staining solution in an Eppendorf, then 20 µl of the 
cell suspension was pipetted into a sealed hemocytometer and viable and dead cell 
concentrations were obtained using an automated cell counter (Invitrogen Countess II 
automated cell counter). 
4.3.4 Cell plating 
Following the concentration achieved above, the cells were diluted to the desired 
concentration (1x105 cell/ml) with supplemented media. Aliquots of 100 µl of the cell 
suspension containing 1 x 105 cells/ml were introduced into each well of a 96-well plate, 
after which 100 µl of growth medium was added. Next, the plate was incubated for 24 
hours at 37  and 5% CO2 incubator to enable the cells to attach. 
4.3.5 Assay 
After a 24-hour incubation period, the medium in the plates was aspirated and the cells 
were treated with 100 µl of the crude extracts (in triplicate) according to the dilutions 
(100, 10 and 1 µg/ml) and 100 µl of media was added to make a final volume of 200 µl. 
These cells were then incubated for 48 hours at 37  and 5 % CO2.  
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For test samples that showed inhibitory activity at 10 µg/ml and less, a series of five 10-
fold dilutions of plant extracts ranging from 100 μg/ml to 0.01 μg/ml was used to 
determine the IC50. 
4.4 MTT assay 
Cell growth was measured using the 3-[4, 5-Dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide (MTT) assay as described by Mosmann (1983). The MTT 
assay is a non-radioactive quantitative colorimetric assay used for in vitro measurement 
of the cytotoxicity and metabolic activity of cell cultures subjected to different culture 
conditions. It is based on the ability of viable cells to reduce the yellow water-soluble 
tetrazolium salt to a water-insoluble purple formazan product. Since this activity requires 
functional mitochondria, only viable cells can cleave the tetrazolium ring. The metabolic 
activity in the cells and the number of viable cells are directly proportional to the amount 
of formazan crystals formed. 
4.4.1 Measuring cell viability 
Once the 48-hour incubation was complete, 25 μl of sterile MTT (5 mg/ml in PBS) was 
added to each well and the plates were incubated for four hours at 37 . The 
supernatant was aspirated from the wells and 100 μl of 100% dimethylsulfoxide 
(DMSO4) was added to each well to dissolve the formazan crystals. The plates were 
gently shaken on a microtiter plate shaker for five minutes and then read immediately 
on a microtiter plate reader at 540 nm. For cell viability analysis, dose-response curves 
were plotted on bar charts with Microsoft Excel.  
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Table 1.  A summary of the names and labels of samples that were evaluated for MCF-7 cell 
growth inhibition. *ND=Not done 
                       Euphorbia tirucalli               Spirostachys africana Euphorbia cupularis 




Barks Stems Leaves Stem Leaves 
Hexane ETD1 ETF1 TB1 TS1 TL1 ECB1 ECL1 
DCM ETD2 ETF2 TB2 TS2 TL2 ECB2 ECL2 
DCM: 
MeOH 
ETD3 ETF3  ND  ND  ND  ND  ND 
MeOH ETD4 ETF4 TB3  ND TL3 ECB3 ECL3 
Ethyl 
acetate 
 ND  ND TB4  ND TL4 ECB4 ECL4 
Water ETD5 ETF5  ND  ND  ND  ND  ND 
4.5 Nitric oxide synthase activity 
The Griess reagent system was used to measure the amount of NO produced by the 
cells after exposure to the plant extracts. The assay relies on a diazotization reaction 
that was first described by Griess. It detects nitrite (NO-2), a stable form of NO, in the 
culture media, which reacts with sulfanilamide and N-1-napthylethylenediamine 
dihydrochloride (NED) under acidic (phosphoric acid) conditions. In this assay, the cell 
culture supernatant (100 μl) taken after 48-hour incubation of the cells with extracts was 
mixed with sulfanilamide (100 μl), incubated for 10 minutes at room temperature and 
then NED solution (100 μl) was added and incubated for 10 minutes. Thereafter, the 
absorbance was measured at 550 nm. The nitrite concentration was calculated from the 
standard curve using nitrite as a standard. 
4.6 LOX activity assay 
LOX activity was determined using the LOX activity assay kit from BioVision. In this 
assay kit, LOX converts its substrate into an intermediate that reacts with the probe, and 
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in doing so, generates a fluorescent product, which is measured on a 
spectrophotometer that can read fluorescence.  
The cells (4 x 105) were homogenized with 100 µl ice-cold LOX buffer and kept on ice 
for 10 minutes, followed by centrifugation at 10 000xg for 15 minutes. The cell lysate (10 
µl) was then mixed with 10 µl plant extract (100, 10 and 1 µg/ml), 20 µl LOX substrate, 2 
µl LOX probe and 78 µl of LOX buffer. The mixture was immediately placed on the 
fluorescence plate reader at an excitation wavelength of 500 nm and emission 
wavelength of 536 nm and the fluorescence was measured at 30-second intervals for 
30 minutes. A standard curve was generated and a LOX inhibitor that came with the kit 
was used as a positive control. The experiment was performed in duplicate and 
repeated twice. 
4.7 Cyclooxygenase-2 activity assay 
Inhibition of COX-2 in MCF-7 cells was determined using the COX activity kit from 
Biovision. The cells (4 x 105) were homogenized with 100 µl ice-cold LOX buffer and 
kept on ice for 10 minutes, followed by centrifugation at 10 000 Xg for 15 minutes. In 
each well, cell lysate (10 µl) was mixed with 10 µl plant extract (100, 10 and 1 µg/ml), 2 
µl COX probe, 4 µl diluted COX cofactor and 74 µl COX assay buffer. The mixture was 
immediately placed on the fluorescence plate reader at an excitation wavelength of 536 
nm and emission wavelength of 587 nm and the fluorescence was measured at 30-
second intervals for 30 minutes. A standard curve was generated and a supplied COX-2 
inhibitor was used as a positive control. The experiment was performed in duplicate and 
repeated twice. All the data was analyzed with Microsoft excel. 





5.1 Plant extraction 
The powdered plant materials were extracted and the percentage yields were 
calculated. The percentage yields are shown in table 2 below. The methanol extract of 
S. africana bark had the highest yield of 39.9% and the lowest was the DCM extract of 
fresh E. tirucalli stems with a 0.12% yield. The dried plant material of E. tirucalli yielded 
more extracts than the fresh. 
Table 2. Yield percentage of plant extracts after extraction with various solvents. [DCM= 
dichloromethane, DCM:MeOH= dichloromethane:methanol 1:1 ratio] *ND=Not done 
  Hexane DCM DCM:MeOH MeOH Ethyl 
acetate 
Water 
 E. cupularis leaves 10.72% 3.4%  ND 3.6% 0.66% 17.2% 
E. cupularis stem 0.12% 7.6%  ND 11.9& 0.3% 4.5% 
S. africana leaves 0.5% 0.7%  ND 21.1% 0.2%  ND 
S. africana bark 5.9% 5.1%  ND 39.9% 5.9%  ND 
S. africana stem 1.9% 0,02% ND  ND  ND  ND 
E. tirucalli aerial parts 
(fresh) 
0.27% 0.12% 0.87% 0.21%  ND 0.53% 
E. tirucalli aerial parts 
(dry) 
1.9% 2.3% 6.3% 1.6%  ND 5.2% 
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5.2 Phytochemical analysis 
The three plants, Euphorbia tirucalli, Spirostachys Africana and Euphorbia cupularis, 
were analyzed to determine the types of phytochemicals present in them. All three 
plants tested positive for the presence of tannins, glycosides and saponins. The bark of 
S. africana tested positive for all the phytochemicals except flavonoids and it was the 
only plant part that contained anthroquines. 
Table 3. Phytochemicals present in E. tirucalli, E. cupularis, and S. africana, (+) means present 
and (–) means absent. 
 E. tirucali              E. cupularis                            S. africana 
  
Plant part aerial parts stems leaves stems leaves barks 
Phytosterols - + - + - + 
Pentose - + - - - + 
Tannins + + + + + + 
Glycosides + + + + + + 
Triterpenoids + + - + - + 
Anthroquines - - - - - + 
Saponins + + + + + + 
Flavonoids - + + - - - 
Alkaloids - - - + + + 
 
Secondary metabolites such as tannins, glycosides, saponins and flavonoids were 
detected in the powdered plant material of Euphorbia Cupularis Boiss leaves and in the 
stem phytosterols, pentose, tannins, glycosides, triterpenoids, saponins and flavonoids.  
In the powdered plant material of S. africana, three parts of the plant were analyzed: 
leaves, stem and bark. In the leaf parts, triterpenoids, tannins, glycosides, saponins and 
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alkaloids were detected. In the stem tannins, phytosterols, glycosides, alkaloids, 
saponins and triterpenoids were detected. 
  
A) Branches, (+) saponins B) Barks, (+) saponins C) Leaves, (+) saponins 
Spyrostachys africana 
C) Stems, pentose B) Leaves, saponins A) Stems, tannins 
Euphorbia cupularis 
Figure 9. Images showing color changes observed during phytochemical testing of S. africana. Frosting 
indicates the presence of saponins, A represents S. africana stems, B= barks and C= leaves. 
Figure 8. Images showing color changes observed during phytochemical testing E. cupularis. Figure 
A shows the presence of tannins, B shows the presence of saponins in powdered  leaves and C 
shows the presence of pentose. A blue-black precipitate indicates tannins, a reddish color showed 
the presence of pentose.  










5.3 Cell culture 
5.3.1 Cell growth inhibition of MCF-7 breast cancer cells 
Extracts of the three plants, S africana (tamboti), E tirucali and E cupularis, were tested 
for their cell growth inhibitory effect on MCF-7 cells using MTT. Extracts were tested in 
triplicate in concentrations of 100, 10 and 1 µg/ml. Most extracts exhibited dose-
dependent cell anti-proliferative activity. Most of the extracts showed 100% inhibition at 
100 μg/ml, while some showed inhibition higher than 50%. The concentration at which a 
plant extract inhibits 50% cell growth is known as IC50. A summary of the results is 
shown in table 4 below. An IC50 that is equal to or less than 10 μg/ml was considered 
good activity, whereas higher than 10 μg/ml was considered poor. 
 
The national cancer guidelines state that an IC50 less than 30 µg/ml is considered 
active (Suffness and Pezzuto, 1990), hence we decided on extracts with an IC50 of 10 
A) saponins B) tannins C) triterpenoids 
Euphorbia tirucalli 
Figure 10. Images showing color changes observed during phytochemical testing of E. tirucalli. Figure A 
shows the presence Saponins, B shows  the presence of tannins and C shows the presence of 
triterpernoids. Triterpernoids are indicated by the presence of a brown interphase. 
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µg/ml or lower. Extracts that showed IC50 of 10 or lower were then tested in six serial 
10-fold dilutions. 
 
Table 4. Cell growth inhibitory activity of extracts of different plant parts of the three plants; S. africana, E. 
tirucali, and E. capularis on MCF-7 cells. X= IC50 higher than 10  μg/ml and ND= not done 
Plant Plant 
part 
Extract and Inhibitory activity 


































































Leaves      
 
Stems 
IC50 10 μg/ml 
 
IC50 10 μg/ml 
IC50<10μg/ml 
        
IC50 10μg/ml 
ND     
 
IC50 10 μg/ml 
           x 
 
x 
         x 
 
IC50 10 μg/ml 
 
5.3.1.1 Cell growth inhibition of MCF-7 cells by extracts of S. africana  
 
The extracts of S. africana obtained from the leaves, stems and bark were tested 
against MCF-7. Of the four extracts of the bark (hexane, dichloromethane, methanol 
and ethyl acetate), hexane and dichloromethane extracts exhibited anti-proliferative 
activity at IC50 values of 10 µg/ml or lower. All leaf extracts showed good activity with 
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IC50 of around 10 µg/ml or lower. The DCM extract of the stem showed activity higher 
than 40% at 1 µg/ml, the results are shown in figure 11. 
 
Figure 11. Cell growth inhibition of MCF-7 cells by S. africana plant extracts. TB= bark extracts, TL= leaf extracts, TS= stem 
extracts, 1= hexane, 2= DCM, 3=MeOH, and 4= ethyl acetate extract 
A series of five 10-fold dilutions of plant extracts ranging from 100 μg/ml to 0.01 μg/ml 
was used to determine the IC50 of the extracts better. The graph of S. africana leaf 
extract revealed that DCM extract (TL2) had the lowest IC50 of 0.09 µg/ml. The extract 
inhibited nearly 40% of cell growth even at the lowest concentration of 0.001 µg/ml. The 
hexane and ethyl acetate (TL1 and TL4) achieved IC50 values of 4 and 6 µg/ml 
respectively, while the highest IC50 was exhibited by methanol (TL3), with an IC50 of 8 
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Figure 12. Cell growth inhibitory of MCF-7 cells by S. africana leaf extracts tested at concentration range of 100 -0.001 µg/ml 
(full 10-fold dilutions). 
The three extracts of the stem and bark (TS2, TB1 and TB2) were selected for full 
dilution based on activity observed from the 3-dilution results. 
 
Figure 13.  Cell growth inhibition of MCF-7 cells by S. africana stem and bark extracts tested at concentration range of 100 -
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Figure 13 shows the growth inhibition activity and IC50 values of selected stem and bark 
extracts. The DCM extract of the bark had the lowest IC50 of 0.8 µg/ml, while the 
hexane bark (TB1) and DCM stem (TS2) extracts both had an IC50 of 11 µg/ml.  
5.3.1.2 Cell growth inhibition of MCF-7 cells by E. tirucalli 
 
The four extracts of Euphorbia tirucalli; hexane, DCM, DCM:methanol (1:1) and 
methanol, were tested against MCF-7 cells. The fresh (wet) and dried plant material 
were extracted. Only the dried extracts of hexane and DCM had an IC50< 10 µg/ml. 
These extracts, exhibited decreased activity at a concentration of 1 µg/ml. The 
DCM:MeOH and MeOH extracts of the stems showed proliferation of MF-7 cells. 
Interestingly, the highest proliferative activity was observed at the lowest concentration. 
All these activities were only observed in dried plant material, the results are shown in 
figure 14 below. 
 
Figure 14.  Cell growth inhibition of MCF-7 by Euphorbia tirucalli extracts.  ETD= dried plant material, ETF= fresh plant 
















Plant extracts of E. tirucalli 





Fresh plant material Dried plant material 
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The plant E. tirucalli yielded the lowest number of extracts that met the criteria. The 
hexane and DCM of the dried parts had a similar IC50 of 9.5 µg/ml. These were selected 
for full range dilutions to obtain the exact IC50 values. Results are shown in Figure 15. 
 
 
Figure 15. Cell growth inhibition of MCF-7 cells by E. tirucalli extracts tested at concentration range of 100 -0.001 µg/ml (full 
10-fold dilutions) 
5.3.1.3 Cell growth inhibition of MCF-7 cells by E. cupularis 
 
The leaf and stem extracts of Euphorbia cupularis were analyzed for their growth 
inhibitory activity. The DCM leaf extract as well as hexane and DCM extracts of the 
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Figure 16. Growth inhibition of MCF-7 cell line by Euphorbia cupularis extracts; ECL represents the leaf extract while ECB 
represents the stems. 1=hexane, 2=DCM, 3=methanol and 4= ethyl acetate 
 
The extracts that had an IC50 below or equal to 10 µg/ml and those that showed 
proliferative activity were then taken further in the studies to determine selectivity and 
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Figure 17. Cell growth inhibition of MCF-7 cells by E. cupularis extracts tested at concentration range of 100 -0.001 µg/ml 
(full 10-fold dilutions). ECL= hexane leaf extract, ECL2= DCM leaf, ECB1= hexane stem, ECB2= DCM stem, and ECB4= ethyl 
acetate stem extract. 
Figure 17 shows the growth inhibitory activity of the E. cupularis MCF-7 cell line.  The 
selected leaf extracts had the lowest activity and the hexane (ECL1) extract showed 
cytostatic behavior from a concentration of 0.01 µg/ml to 1 µg/ml with about 50% 
growth inhibition maintained in that range of concentration. The IC50 was determined as 
0.6 µg/ml, which is the same as that of DCM (ECL2). The ethyl acetate (ECB4) and 
DCM (ECB2) stem extract had a slightly similar IC50 of 1 µg/ml and 1.2 µg/ml 
respectively. The hexane stems extract exhibited the highest IC50 of 5 µg/ml.  
 
5.3.2 Selectivity of extracts for breast cancer cells 
The extracts that had an IC50 below or equal to 10 µg/ml and those that showed 
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cancer cell line. The selected extracts were screened for inhibitory activity against the 
breast normal cell line MCF-10A, and CHO cell line.  
Spirostachys africana leaf extracts showed low anti-proliferation against normal breast 
cells compared to breast cancer cells. The hexane extract (TL1) that had the highest 
activity against cancer cells showed the least activity against normal breast cells. Ethyl 
acetate extract (TL4) also had good selectivity, meaning that S. africana leaves 
selectively inhibited breast cancer cell growth.   
 
Figure 18. Cell growth inhibition of MCF-7 cells by extract of tamboti leaves and E. cupularis stems. TL= S. africana leaf 
extracts, TB= S. africana bark extracts and ECB= E. cupularis stem extracts.  1=hexane, 2=DCM, 3=methanol and 4= ethyl 
acetate  
Other extracts were tested on the CHO cells instead of the normal breast cells (as the 
normal breast cells grew slowly and required costly growth supplements). The E. 
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concentration at only 11%. This was followed by the stem extracts of the same plant, 
with the ethyl acetate extract (ECB4) showing 49% growth inhibition at 100 μg/ml.  
 
 
Figure 19. Cell growth inhibition of CHO cells by extracts of E. tirucalli (ETD3= DCM:MeOH and ETD4= MeOH), E. cupularis 
leaves (ECL1= hexane, ECL2= DCM extracts) and stems (ECB1= hexane, ECB2 DCM, ECB4 ethyl acetate extract), and S. africana 
stems (TS2= DCM extract).  
The selectivity index (SI) was then calculated using a method described by Badisa et al 
(2009). An SI of less than 2 is regarded as not selective, and in the extracts tested only 
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Table 5. Selectivity index of selected extracts 
Extract IC50 in normal breast 
cells or CHO cells 
IC50 in cancer cells Selectivity Index (SI) 
TL1 122 4 30,50 
TL2 62 0,09 688,88 
TL3 15 8 1,88 
TL4 110 6 18,33 
TS2 20 11 1,82 
TB1 49 11 4,45 
TB2 7 0,8 8,75 
ECL1 30 0,6 50,00 
ECL2 150 0,6 250,00 
ECB1 20 5 4,00 
ECB2 7 1,2 5,83 
ECB4 105 1 105,00 
 
The extracts that showed considerable anti-proliferative activity and those that showed 
proliferative behavior were taken further to understand their mode of action through 
determining their effects on LOX, COS and NOS enzymes. 
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5.4 Enzyme activity assays 
 
5.4.1 NOS activity 
NOS activity was determined by measuring the amount of NO present in the culture 
media after incubating the cells with the plant extract for 24 hours. A standard curve 
(figure 20) was created and used to determine the concentration of NO, by determining 
the levels of nitrite, a stable form of NO.  
 
Figure 20. Nitrite standard curve 
Figure 21 below shows the activity of NOS against selected extracts. These results 
show that the levels of NO increase with the concentration of extracts.  
y = 5E-05x + 0,0474 
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Figure 21.  Effects of selected extracts of S. africana, E. tirucalli, and E. cupularis on NOS activity. TL= S. africana leaf extracts 
(1= hexane,2= DCM, 3= MeOH, and 4= ethyl acetate), TB= S. africana bark extracts (1= hexane, 2= DCM), ECB= E. cupularis 
stem extracts (1=hexane, 2= DCM, 4= ethyl acetate), ECL= E. cupularis leaf extracts(1= hexane, 2= DCM), ETD= E. tirucalli 




COX-2 is the inducible isoform of COX; when induced it produces prostaglandins that 
induce inflammation and tumor angiogenesis (Chang et al, 2004).  In this study, we 
determined the effects of the selected extracts on COX-2 using the COX activity assay 
kit from Biovision. The inhibitory effects of the extracts were determined in a kinetic 
study, as shown with the relative fluorescence units (RFU) per time graphs below. From 
the kinetic graphs, enzyme activity was calculated by deducing the gradient and 
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Figure 23 shows the kinetic activity of COX control enzyme with and without a positive 
control inhibitor. The enzyme has higher activity than the enzyme inhibitor and both 
systems follow a similar trend over time. The behavior of the enzyme does not seem to 
be altered during inhibition; only the amount of product formed is altered. Thus, in the 
presence of an inhibitor, less product formation is observed. 
y = 1482,4x + 505,89 
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Figure 23. Enzyme kinetic activity of COX enzyme with (Enz + inh) and 
without a commercial inhibitor (enzyme).   






The same behavior was noticed with the enzyme isolated from MCF-7 cells, where 
concentration-dependent inhibition was observed. Figure 24 shows the kinetic behavior 
of COX against the leaf extracts from S. Africana.  The non-polar extracts, (TL1 and 




Figure 24. The graphs show the effect of leaf extracts of S. africana on activity of COX-2 over time. Figure A shows the effect of hexane 
leaf extract, B is DCM leaf extract, C is the methanol leaf extract, D is the ethyl acetate leaf extract and E shows the hexane bark extract.
  




Figure 25. The graphs show the effect of S. africana hexane bark extract on activity of COX-2 over time. 
Hexane bark extract of S. africana induced a slightly similar activity at 100 and 10 μg/ml, 
with the highest inhibitory activity at 10 μg/ml. 
 
  
However, other extracts showed a different trend; for example, the hexane and DCM 
Extracts of E. cupularis leaves (ECL1 and 2) showed an increase in activity with 
increasing extract concentration, but there was no distinguishable activity between 
concentrations 1 and 10 μg/ml. 
Figure 26. The graphs show the effect of E. cupularis leaf extracts on activity of COX-2 over time. Figure A shows the effect of DCM 
extract and B shows that of hexane extract. 





Another interesting trend was observed with ethyl acetate extract of E. cupularis stems 
(ECB4): the activity decreased rapidly in the first minute and then increased steadily for 
20 minutes, the results are shown in figure 27. 
Figure 27. The graphs show the effect of E. cupularis stem extracts on activity of COX-2 over time.  Figure A shows the effect of hexane 
extract, B shows the DCM extract and C shows ethyl acetate extract.  




Figure 28. Activity of COX-2 against selected extracts, where the tve control represents positive control, a pure enzyme 
supplied, and enz + inh is the pure enzyme with celecoxib (COX-2 inhibitor) added. 
Figure 28 shows activity of COX-2 against the selected extracts. This activity was 
determined from the kinetic studies shown above. The results show that COX-2 was 
inhibited in a concentration-dependent manner and TB1 was most active. The DCM 
extract, however, showed increasing enzyme activity with increasing extract 
concentration, while the ethyl acetate of S. africana and E. cupularies showed no 
distinguishable concentration activity. Compared to celecoxib, a known inhibitor of COX-
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5.4.3 Lipoxygenase activity 
 
The effect of the plant extracts on LOX was determined using a kinetic study. The RFU 
time graphs are shown below. The results show concentration-dependent inhibition of 
LOX by all the plant extracts. LOX activity was determined in the same manner as COX 
activity. The standard curve is shown below. 
 
Figure 29. LOX standard curve 
The kinetic characteristics of the controls are shown in figure 29 below. The graph 
shows that the activity of the LOX from MCF-7 lysate is more than that of the pure 
enzyme (PC) supplied; however, when a known inhibitor is added the LOX lysate 
becomes inactive. 
 
y = 6325,9x + 2676,3 
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Figure 30. Kinetic activity of LOX enzyme.  PC= Positive control (Pure enzyme obtained commercially), S= MCF7 untreated 
cells, SI=Inhibitor added to MCF-7 cells (inhibitor obtained commercially). High RFU is indicative of high LOX activity. 
 
AS shown in figure 30, MFC-7 cells showed highest LOX activity overtime, followed by the 
Positive control, which was a pure LOX enzyme obtained commercially. The results showed that 
the commercial inhibitor did inhibit the activity of LOX. The result proof that the assay worked 

































The effect of S. africana leaf extracts on LOX kinetic activity are shown in figure 31. 
Hexane extract shows slightly similar activity at 10 and 1 μg/ml, thus no significant 
difference was observed.  
 
 
Figure 32.   The graphs show the effect of S. africana bark extracts on activity of LOX over time. Figure A shows hexane bark 
extract and figure B shows the DCM bark extract. TB1= hexane extract and TB2= DCM extract. 
Figure 31. The graphs show the effect of S. africana leaf extracts on activity of LOX over time. Figure A shows the effect of hexane 
leaf extract, B is DCM leaf extract, C is the methanol leaf extract.  
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The effect of S. africana bark extracts on LOX kinetic activity are shown in figure 32. 
Both TB1 and TB2 have a similar activity at concentration of 10 and 1 μg/ml. TB1 also 




Euphorbia cupularis was tested for its effect on LOX over time in figure 33. Ethyl acetate 
extract of the stems shows a steady increase in LOX activity from 0 minutes to 10 
minutes and from 10 minutes onwards that activity increases exponentially.  
 
Figure 33.  The graphs show the effect of E. cupularis stem extracts on activity of LOX over time.  Figure A shows the effect of 
hexane extract, B shows the DCM extract, and C shows ethyl acetate stem extract. D shows hexane leaf extract and E shows DCM 
leaf extract. 




Figure 34.  The graphs show the effect of E. cupularis stem extracts on activity of LOX over time.  Figure A shows the effect of 
hexane extract, B shows the DCM extract 
 
The leaf extracts of E. cupularis also showed a concentration dependent inhibition and 





Euphorbia tirucalli was the least active of the plants tested. The DCM:MeOH and 
methanol extracts were the only extracts tested. The methanol extract showed a higher 
increase in activity over time, while the ETD3 was more static over time (figure 35). 
Figure 35. .  The graphs show the effect of selected E. tirucalli extracts on activity of LOX over time. Figure A shows the effect 
of DCM:MeOH extract and B shiows the methanol extract.  






Figure 36. Activity of LOX following exposure to  selected extracts. PC= positive control (pure enzyme obtained commercially) 
and sample = untreated MCF-7 cells . 
The kinetic activity results were used to determine LOX activity based on the 
concentration of the product formed, figure 36 shows the results. The results show that 
inhibition was concentration-dependent, with ETD4 having the least inhibitory activity; in 
fact the LOX activity of ETD4 was higher than that of the positive control. This may 
suggest that ETD4 induces LOX activity rather than inhibiting activity. However, when 
comparing the activity of other extracts with the sample that had no extract, the activity 
was similar, which may suggest that the other extracts did not affect LOX activity; only 
ETD4 showed distinguishable activity.  
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Plants produce secondary metabolites as defense against pathogens and harsh 
environmental conditions. These metabolites, which are known as phytochemicals 
(Bennett & Wallsgrove, 1994), are important in cancer treatment owing to their 
antioxidant, anti-inflammatory and anti-mutagenic activities (Kaur et al, 2018). 
 
Figure 34: Bioactive secondary metabolites from medicinal plants (Kaur et al, 2018).  
In the stems of Euphorbia tirucalli, tannins, glycosides, triterpenoids and saponins were 
detected. In phytochemical studies of E. tirucalli from Jaipur city in India, researchers 
detected the presence of alkaloids, coumarins, triterpens, polyphenols and tannins 
(Upadhayah et al, 2010). However, we did not detect alkaloids. This proves that the 
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same plant species growing in different geographical locations produce different 
secondary metabolites, since they face different environmental conditions.  
In previous studies, the stem bark of S. africana ethanolic extract was analyzed for 
phytochemicals using silica gel column chromatography. It was found to contain 
diterpenoids and triterpenoids (Mathebe et al, 2008). This confirms our analysis of the 
bark of S. africana in which we found triterpenoids in the powdered plant part. 
Tannins, flavonoids and glycosides have been shown to have anti-inflammatory and 
anti-oxidant activity (Nascimento et al, 2017). Inflammation is related to tumor 
metastasis and the enzyme responsible for inflammation is COX-2, an enzyme that is 
known to promote tumor angiogenesis. Antioxidant activity removes reactive oxidation 
species in the body that are known to cause cancer (Rice-Evans et al, 1997). Tannins 
also display anti-cancer and anti-allergic activity, specifically relating to hypersensitivity 
to food (Li & Wang, 2003; Akiyama et al, 2005). Alkaloids have been reported to show 
analgesic, anti-angiogenic anti-spasmodic and antibacterial activity (Yadav & Agarwala, 
2011; Khalid et al, 2016). Glycosides are known to reduce hypertension and saponins 
have anti-inflammatory activity (Nyarko & Addy, 1990; Just et al, 1997). Tannins, 
saponins and glycoside were present in all the powdered plants, whereas alkaloids 
were only present in S. africana and flavonoids in E. cupularis. The presence of these 
phytochemicals could be the result of anti-cancer activity observed in these plants. 
However, it has been shown that plant phytochemicals usually work in synergy to exert 
activity (Liu, 2004), it can therefore be a combination of these phytochemicals that 
resulted in the anti-cancer activity observed in the plants tested. Further study is 
required to determine this. 
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To determine anti-cancer activity, the MCF-7 breast cancer cells were exposed to the 
extracts. The extracts that had an IC50 of 10 μg/ml or lower were considered active and 
were selected for further studies. The national cancer institute regards an IC50 of less 
than 30 μg/ml as active (Suffness and Pezzuto, 1990). The extracts that also showed 
proliferation were selected. E. tirucalli was the only plant that exhibited this trend.  Both 
dried and fresh plant materials were extracted. The yield was found higher in dried 
material than in fresh. Furthermore, cell growth inhibition activity was also found in dried 
material. The hexane and DCM extracts of the dried plant material exhibited 
considerable activity in the range of 10 µg/ml. The latex of this plant, which is known to 
be poisonous, did not show activity either. It therefore seems that drying concentrated 
and/or preserved the phytochemicals present in the plant. However, in another study it 
was found that drying reduced the total phenolic content and anti-oxidant activity of that 
plant (Barimah et al, 2017), but that study focused on solar and oven drying, while we 
placed our plant away from direct sunlight. 
The non-polar extracts of S. africana showed the highest activity in the range of 1 μg/ml, 
while the more polar extract (methanol) had reduced activity, which implies that the 
bioactive secondary metabolites in the plant are non-polar. The leaf extracts showed 
higher activity than the roots, while the bark extract showed comparative activity of 9 
μg/ml to 15 μg/ml. The non-polar extracts of E. cupularis stem and leaves also showed 
high cell growth inhibition.  
The extracts were then tested for selectivity using the epithelial breast cell MCF10A and 
Chinese hamster ovarian cell lines. The SI was determined for all extracts that were 
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tested against cancer and normal cells. Of all the extracts tested, only TL3 was 
nonselective and the most selective was TL2. 
All S. africana leaf extracts, except methanol, exhibited selectivity against MCF-7 breast 
cancer cells. This therefore implies that this plant part is a good candidate for targeted 
anti-cancer treatment drug development. Other extracts were tested on CHO cells. The 
E. tirucalli extracts were also nontoxic to these cells; instead they had a proliferative 
effect on CHO cells. The DCM extract of E. cupularis was least toxic of the extracts 
tested on CHO cells. The powdered material of all the extracts that showed selectivity 
had the lowest number of phytochemical constituents tested. All these extracts had 
tannins, saponins and glycosides. E. tirucalli had triterpenoids, E. cupularis had 
flavonoids and S. africana leaves had alkaloids as the distinguishing phytochemicals. 
The DCM extract of E. cupularis stem was most toxic to both cell types and had 
phytosterols, pentose, triterpenoids and flavonoids in addition to the common three 
phytochemicals. We can therefore assume that there is a synergic relationship with 
these absent phytochemicals in all the extracts that are present, which makes E. 
cupularis DCM extract lethal. We can also assume that the presence of alkaloids in S. 
africana leaves and the presence of flavonoids in E. cupularis leaves result in 
selectivity. 
 
The selected extracts were then analyzed for NO activity in MCF-7 cells. The results 
showed that the extracts that had low cell growth inhibition also induced very low NO 
activity. These were E. tirucalli extracts.  E tirucalli plant extracts exhibited very little NO 
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production and also induced proliferation of CHO cells, which might suggest that they 
induce tumor angiogenesis. The results also suggested a direct proportional increase in 
NO concentration to growth inhibition. Therefore the extracts that induced growth 
inhibition also induced NO activity. Since these extracts induce cell growth inhibition of 
the cancer cells used, this also shows that high levels of NO in the cells result in cell 
death (Kumar & Kashyap, 2015). NO has been known to induce angiogenesis and 
tumor metastasis; however, high levels of NO promote apoptosis (Tschugguel et al, 
1999). Therefore NO has cancer-promoting activity at low levels and anti-cancer activity 
at high levels. In our research, we observed that the levels of NO produced by the effect 
of the selected plant extracts showed anti-cancer activity, and perhaps the low levels 
seen in cells treated with E. tirucalli extracts, which resulted in proliferation, could be an 
indication of induction of tumor angiogenesis. 
Inhibitory effects of selected extract on COX was studied to determine whether the 
extract affected angiogenesis. Relative to the control, all the extracts tested inhibited 
COX activity. S. africana hexane bark extracts inhibited COX-2 more than other 
extracts. Inhibitory activity at 10 and 100 μg/ml was not distinguishable, which could 
mean that saturation was reached at 10 ug/ml. Extracts that showed dose-dependent 
inhibition of COX included TL1, ECB1, ECB2, and ECL1. This indicates that COX-2 
inhibitors are non-polar, since the extracts that showed inhibitory activity were hexane 
and DCM of S. africana leaves and E. cupularis stems and leaves. To the best of our 
knowledge no inhibition studies of COX-2 isolated from MCF-7 cell have been reported 
yet. However, in another study, more COX inhibitory activity was found in ethanol, a 
polar solvent extract, than in hexane, a non-polar extract (Shaikh et al, 2016). This is 
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why medicinal plants are a field of interest; they offer new and attractive sources of 
medicine and lead compounds. 
To investigate the effects of plant extracts on angiogenesis further, LOX inhibition 
studies were conducted. LOXs convert arachidonic acid to hydroperoxyoxyeicosa-6E, 
8C, 11Z, 14Ztetraenoic acid (HETE) (Avis et al, 2001).  Both LOX and COX have an 
arachidonic acid as their substrate to form eicosanoids (Chi et al, 2001). The plant 
extracts exhibited dose-dependent inhibition of LOX; however, the difference in activity 
between the concentrations is very low compared to the control. The methanol extract 
of E. tirucalli is the only extract with distinguishable activity; however, instead of 
inhibitory activity, the extract showed inducible activity. This activity decreased with 
increasing extract concentration. The same extract was found to induce proliferation in 
MCF-7 cells, therefore at a low concentration, this extract may induce angiogenesis by 
inducing LOX activity. 
 
 In another study, inhibition of 5-LOX was shown to induce apoptosis in MCF-7 cells 
(Avis et al, 2001). This may also suggest that our extracts induce apoptosis through a 
different mechanism that does not involve LOX. Moreover, MK886, a LOX inhibitor, is 
known to be effective in vivo, but in the cell lysate it has no effect (Rouzer et al, 1990). 
Therefore there is a possibility that our extract may inhibit LOX in vivo. Some 
compounds need to be metabolized to be active. They behave like pro-drugs, hence 
they are non-active in vitro but become active in vivo. 
  




The results showed that E. tirucalli had low cytotoxicity against MCF-7 and CHO cells, 
and only three classes of phytochemicals tested positive. They also showed that DCM 
and methanol extracts of E. tirucalli might possess proliferative activity, while the 
methanol extracts may also induce angiogenesis through induction of LOX activity. The 
extract had low NOS activity, which might also explain the proliferative activity 
observed.  
The stems and leaf parts of Euphorbia cupularis were investigated. E. capularis is the 
only plant that had flavonoid content. Hexane and DCM extracts of both the stem and 
leaves, as well as the ethyl acetate extract of the stem, showed good anti-proliferative 
activity. This was confirmed by relatively good NOS activity. The extracts also had good 
selectivity based on the SI. ECB1, ECB2 and ECL1 at 10 to 100 ug/ml, as well as ECB4 
at all concentrations, induced high COX-2 inhibition, which may suggest that E. 
capularis might inhibit angiogenesis through COX-2.  
Spirostachys africana had the highest phytochemical composition and activity. All the 
leaf extracts had anti-proliferative activity and were also selective towards MCF-7 cells. 
The leaf extracts induced NOS activity as well. The extracts further exhibited inhibitory 
activity against COX-2, suggesting that they may inhibit angiogenesis by inhibiting COX-
2 activity. The hexane and DCM extracts from the bark also had good anti-proliferation 
and NOS activity; however, they did not have a considerable effect on LOX and COX-2 
enzymes. This suggests that they only induce apoptosis through the activation of NOS, 
as perhaps one of the mechanisms.   
© Central University of Technology, Free State
69 
 
To the best of our knowledge, no studies have described the effect of the medicinal 
plants used in this study on angiogenesis. More research is under way to characterize 
the active constituents contained in these plants further. Some of the results are 
contradictory to the traditional use of the plants. S. africana and E. cupularis are 
traditionally used for wound healing and we found anti-cancer activity in the plants. E. 
tirucalli is traditionally used to cure cancer, but we found no (strong) anti-cancer activity 
in vitro. E. tirucalli is also used traditionally for wound healing, and the results agree with 
this. The plant showed growth inhibition at a concentration of 100 ug/ml, which we do 
not (according to NCI guidelines) consider good activity. 
It is difficult to make concrete conclusions based only on in vitro studies. More studies in 
vivo are needed to draw proper conclusions. 
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Abstract 
Angiogenesis is implicated in tumor growth, metastasis and wound healing. During tumor 
metastasis, this process is amplified as new capillaries are needed for cancer to spread, but in 
ulcerations, when this process does not occur, ulceration does not heal. Cyclooxygenase-2 
(COX-2), Nitric oxide synthase (NOS) and lipoxygenase (LOX) are some of the enzymes that 
are highly expressed during angiogenesis, and therefore provide a useful way to detect 
angiogenesis. Some medicinal plants have shown to possess angiogenetic-modulating 
properties, which has led to development of anti-angiogenic drugs. Spirostachys Africana Sond 
has traditionally been used for treatment of open wounds, ulcers and cancer. Its mechanism(s) 
of action is however still not clear. The aim of the study is to elucidate mechanisms of anti-
cancer and wound healing activities of Spirostachys Africana by evaluating its angiogenesis 
modulating effects, through determination of its growth inhibitory effects on MCF-7 cells as well 
as its inhibitory effects on COX-2, LOX and NOS enzymes. The dried plant materials were 
extracted with water and sequentially with organic solvents in order of increasing polarity. 
Extracts were screened for cell growth inhibitory activity against breast cancer MCF7 cells, and 
for selectivity against normal breast MCF-10A cells, and CHO cell line. Extracts that showed 
growth inhibitory activity with IC50 values <10ug/ml were further evaluated for effects on COX-2, 
LOX, and NOS enzymatic activity. The nonpolar extracts of all plant parts had anti-proliferation 
activity with IC50 around 10 μg/ml or lower. All the leaf extracts showed selectivity for MCF-7 
breast cancer. The selected extracts also induced NOS activity and inhibited LOX and COX 
activity in a concentration dependent manner. It was concluded that the selected extract may 
inhibit angiogenesis by inhibiting COX and LOX, and induce apoptosis by increasing NOS 
activity. S. Africana was found to contain tannins, glycosides, saponins and alkaloids which 





Angiogenesis is the processes of forming new capillary vessels from existing ones. It is a 
normal biological process that occurs during the female reproductive cycle, wound- healing, and 
Keywords: Angiogenesis, Spirostachys Africana, cyclooxygenase-2, lipoxygenase, MCF-7 breast 
cancer, nitric oxide synthase 
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treatment of ulcers (Nishida et al, 2006). Studies have shown that abnormal angiogenesis is 
related to tumor growth and progression to a metastatic phenotype (Folkman, 1971). For 
metastasis to occur, new vessels are required to supply the tumor with nutrients and oxygen 
(Nishida et al, 2006). Furthermore, angiogenesis is complex process that involves growth 
factors, cytokines and enzymes such as cyclooxygenases, nitric oxide synthase and 
lipoxygenase.  
Cyclooxygenases (COX) are the enzymes that catalyze the oxidation of a wide variety of 
xenobiotics, including prostaglandins (Smith et al, 1991). COX-2 is inducible and functions in 
inflammation and tumor angiogenesis (Sano et al, 1995; Kujubu et al, 1993). 
Lipoxygenases (LOX) are group of enzymes with a non-heme iron atom that catalyze the 
oxidation of poly-unsaturated fatty acids like arachidonic acid (Wisastra & Dekker, 2014). 
Expression of 12-LOX in prostate cancer was found to induce tumor angiogenesis (Nie et al, 
1998). More 5-LOX transcripts were found in brain tumors than in normal bovine brain (Boado et 
al, 1992), and 5(S)-hydrooxyeicosa-6E,8C,11Z,14Z-tetraenoic acid (5-HETE), a product of 5-
LOX, stimulated growth whereas a 5-LOX selective inhibitor reduced growth in breast cancer 
cells (Avis et al, 2001). 
Nitric oxide synthase (NOS) form nitric oxide from L-arginine. Cianchi et al (2003) found 
elevated levels of iNOS and VEGF in colorectal cancer, and a high activity of iNOS in metastatic 
tumors than in non-metastatic ones. Thus, these three enzymes in particular, COX-2, LOX and 
NOS, have been selected as the focus of the study due to their significant role in angiogenesis 
and their implication in tumor initiation and growth. 
Spirostachys Africana Sond is a member of the family Euphorbiaceae and is found all over the 
Southern Africa and also in the Central Africa (Palgrave, 1990). In South Africa, the stem and 
bark are used to treat stomach pains, stomach ulcers, kidney complaints and cough and eye 
complaints (Mabogo, 1990; Cocks & Dolds, 2000; McGaw et al, 2000; Verschaeve et al, 2004; 
Mathabe et al, 2006). Crude extracts from the bark of this plant have shown antibacterial activity 
against bacteria that cause diarrhea (Mathabe et al, 2006). The aim of the study is to investigate 
Spirostachys africana for its effect on growth of MCF-7 breast cancer cell line, and its 
angiogenesis modulating properties, by determining its inhibitory effects on COX-2, LOX and 
NOS enzymes, which are involved in tumour angiogenesis. MCF-7 cells were selected for the 
study as it has characteristics of a tumor, such as enzyme expression (Soule et al, 1973; Kumar 
& Kashyap, 2015). 
Materials and Methods 
 
Plant collection and extraction 
The plants were collected from Pretoria and Kruger National Park, Limpopo Province, South 
Africa during  the summer season. The dried plant material were then ground, weighed, then 
extracted with water or organic solvents in order of increasing polarity (hexane, DCM, methanol) 
and left to shake them for 48h before filtering. Filtrates were concentrated by freeze drying (for 
© Central University of Technology, Free State
85 
 
water extracts) and by rotatory evaporation for organic extracts. Percentage yields were 
calculated.   
Phytochemical analysis 
The powdered plant material was subjected to different methods for determination of 
phytosterols, pentose, tannins, glycosides, triterpenoids, anthroquines, saponins, flavonoids, 
and alkaloids (Yadav & Agarwala, 2011). 
Cell culturing 
 
MCF-7 cells were grown in DMEM supplemented with 10% FBS and 0.6% streptomyscin. The 
culture environment was maintained at 37°C in humidified, concentrated CO2 (5%) atmosphere. 
Cells were sub-cultured once they reached ~80% confluency following methods described by 
(Huang et al, 2010). Cell viability was determined by trypan blue staining, and automated cell 
counter was used to obtain a cell concentration of 1x105 cells/ml that was used in all 
experiments. The cells were plated in 96-well plate and incubated for 24 hours to adhere. After 
a 24 hour incubation period, the medium was aspirated and the cells were treated with 100 µl of 
the crude extracts (in triplicate) according to the dilutions (100, 10 and 1 µg/ml) and 100 µl of 
media was added to make a final volume of 200 µl. Cell proliferation was measured by MTT 
assay (Mosmann 1983) following a 48 hour incubation. Absorbance was read at 540 nm 
wavelength.  
Selectivity was assessed on non-cancerous normal MCF-10A and CHO cells. Cells were grown 
in EMEM supplemented with epidermal growth factors, and in DMEM: HAMS F12 (1:1) 
respectively. Both media were supplemented with 10% FBS.  
 
Nitric oxide synthase activity 
 
The Griess reagent system was used to measure the amount of nitric oxide (NO) produced by 
the cells after exposure to the plant extracts. The assay relies on a diazotization reaction that 
was first described by Griess. It detects nitrite (NO-2), a stable form of NO, in the culture media 
which reacts with sulfanilamide and N-1-napthylethylenediamine dihydrochloride (NED) under 
acidic (phosphoric acid) conditions. In this assay, cells (1x105 cells/ml) were incubated with the 
extracts at different concentration for 48hrs. The cell culture supernatant (100 μl) was obtained 
from culture and mixed with sulfanilamide (100 μl). The mixture was incubated for 10 minutes at 
room temperature and then NED solution (100 μl) was added and incubated for 10 minutes. 
Thereafter, the absorbance was measured at 550nm. The nitrite concentration was calculated 
from nitrite standard curve. Cells without extract were used as negative control. 
LOX activity assay 
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Lipoxygenase activity was determined using the lipoxygenase activity assay kit from BioVision. 
In this assay, Lipoxygenase converts its substrate into an intermediate that reacts with the 
probe, and in doing so, generates a fluorescent product which is measured with a 
spectrophotometer. 
The cells (4 x 105 cells/ml) were homogenized with 100 µl ice-cold LOX buffer and kept on ice 
for 10 minutes, followed by centrifugation at 10 000 Xg for 15 minutes. The cell lysate (10 µl) 
was then mixed with 10 µl plant extract (100, 10 and 1 µg/ml), 20 µl LOX substrate, 2 µl LOX 
probe and 78 µl of LOX buffer. The mixture was immediately placed on the fluorescence plate 
reader at an excitation wavelength of 500 nm and emission wavelength of 536 nm and the 
fluorescence was measured at 30 seconds interval for 30 minutes. Standard curve was 
generated from the LOX substrate and pure LOX enzyme supplied. LOX inhibitor was used a 
positive control. The experiment was performed in duplicates and repeated twice. 
 
Cyclooxygenase-2 activity assay 
 
Inhibition of COX-2 in MCF-7 cells was determined using cyclooxygenase activity kit from 
Biovision. The cells (4 x 105 cells/ml) were homogenized with 100 µl ice-cold LOX buffer and 
kept on ice for 10 minutes, followed by centrifugation at 10 000 Xg for 15 minutes. In each well, 
cell lysate (10 µl) was mixed with 10 µl plant extract (100, 10 and 1 µg/ml), 2 µl COX probe, 4 µl 
diluted COX cofactor and 74 µl COX assay buffer. The mixture was immediately placed on the 
fluorescence plate reader at an excitation wavelength of 536 nm and emission wavelength of 
587 nm and the fluorescence was measured at 30 seconds interval for 30 minutes. A standard 
curve was generated and a supplied COX-2 inhibitor was used a positive control. The 
experiment was performed in duplicates and repeated twice. 
Results 
The ground plant material was extracted and the yields are shown in table 1 below. Methanol 
extracts had the highest yield for both leaves and barks while the lowest yield was observed in 
DCM stem extract. 
Table 6. The percentage yield of extracts from powdered material 
  hexane DCM MeOH 
ethyl 
acetate 
S. africana leaves 0.5% 0.7% 21.1% 0.2% 
S. africana barks 5.9% 5.1% 39.9% 5.9% 
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In the powdered plant material of S. africana, three parts of the plant were analysed; leaves, 
stem and barks. In the leaf parts, triterpenoids, tannins, glycosides, saponins and alkaloids were 
detected. In the stem tannins, phytosterols, glycosides, alkaloids, saponins and triterpenoids 
were detected. All the phytochemicals were present in the barks except for flavonoids, which 
were absent in all plant parts. 
Table 7. Phytochemicals tested in S. Africana, + indicates present and – present absent 
 stems leaves bucks 
Phytosterols + - + 
Pentose - - + 
Tannins + + + 
Glycosides + + + 
Triterpenoids + - + 
Anthroquines - - + 
Saponins + + + 
Flavonoids - - - 
Alkaloids + + + 
 
Cell growth inhibition studies 
 
 
Figure 37. Effects  of S. africana extracts on MCF-7 cell growth inhibition . TB represents the bark extract, TL the leaf and TS 
represents the stem extract. 1= hexane, 2= DCM, 3= methanol and 4= ethyl acetate. 
Each plant part: stem, leaf and bark had 2 to 4 extracts. The bark had 4 extracts: hexane (TB1), 
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and dichloromethane had the anti-proliferative activity with IC50 of 10 µg/ml or lower. All the leaf 
extracts showed considerable activity with IC50 ranging from 1ugml to 10 µg/ml. For the stem 
extracts, only the DCM extract (TS2) showed anti-proliferation activity. 
Selectivity 
 
Selectivity of the extracts was studied by determining their anti-proliferative activity against the 
normal human breast MCF-10A cells. All the leaf extracts showed low anti-proliferation against 
normal breast cells compared to activity against breast cancer cells. The hexane extract (TL1), 
which had the highest cytotoxic activity against the cancer cells, showed the least activity of all 
the extracts, indicating that S. Africana leaves selectively inhibited breast cancer cell growth. 
Extracts that showed IC50 of 10ug/ml and below showed reduced inhibition (20% inhibition and 
less) at the same concentration against the normal breast cell line. The leaf extracts showed 





Figure 38. Effects of S. africana bark and leaf extracts on normal human breast MCF-10A cell growth inhibition 
NOS inhibition studies 
 
Figure 3 shows the results of nitric oxide synthase activity against plant extracts. The results 
show that the levels of nitric oxide increased with the concentration of extracts. The hexane and 
DCM extracts of the both the leaves and barks exhibited high levels of NO (over 1000 and 2000 
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the extract. The two nonpolar extracts (TL1, TL2, TB1 and TB2) exhibited highest inhibition 





Figure 39. The effect of S. africana extracts on nitric oxide synthase 
 
COX-2 inhibition studies 
 
The results in figure 4 show that COX-2 was inhibited in a concentration dependent manner. 
The hexane extract of the bark-(TB1) exhibited the highest inhibition withenzyme activity of 
~0.26 pmol/μl at 100 μg/ml), compared to celecoxib, a known inhibitor of COX-2 which had 
























   








Figure 40. Activity of COX-2 against S. africana extracts, where tve contrl represents positive control ( pure enzyme supplied) 
while enz + inh is the pure enzyme with celecoxib (COX-2 inhibitor). N=2   
2   
 
LOX inhibition studies 
LOX activity was determined by measuring RFU and deducing concentration from the LOX 
standard probe. The results are shown in figure 5, and they show a concentration dependant 
inhibition with methanol leaf extract (TL3) showing the lowest inhibition (0.81 pmol/μl) at 100 
μg/ml. The negative control had activity of 0.91 pmol/μl, which is similar that of TB1 at 1 μg/ml 



































Figure 41. Effects of selected extracts on the activity of LOX enzyme. PC= positive control and sample = cells without extract. 
Discussion 
 
Spirostachys Africana tested positive for many of the secondary metabolites, including tannins, 
glycosides, saponins and alkaloids. In previous studies, the stem and bark of S. africana 
ethanolic extracts were found to contain diterpenoids and triterpenoids (Mathebe et al, 2008). 
This corroborates with our findings.   
Tannins, saponins, flavonoids and glycosides have been shown to have anti-inflammatory and 
anti-oxidant activity (Nascimento et al, 2017). Inflammation is related to tumour metastasis and 
cyclooxygenase-2  is implicated in both.  Tannins also have anticancer activity (Li & Wang, 
2003; Akiyama et al, 2005). Glycosides are known for several biological activities including 
toxicity and anti-inflammatory activity (Nyarko & Addi, 1990; Just et al, 1997). We also observed 
that all the non-polar solvents had the highest activity, suggesting that the active 
phytochemicals are non-polar. The non-polar and semi-polar phytochemicals that could be 
present in the plant include alkaloids, phytosterols and triterpenoids (Widyawati et al, 2014). The 
leaf extracts selectively inhibited MCF-7 breast cancer cells over MCF-10A normal breast 
epithelial cells. The leaves only tested positive for alkaloids while the stem and barks tested 
positive for all three, which may suggested that the compound(s) with selectivity could be an 
alkaloid. However, this would only be verified after our future study has been completed, which 
is on the isolation and identification of pure compounds from this plant species, especially 
alkaloids. 
 
Angiogenesis is the key process in wound healing and, tumor growth and metastasis. Complete 
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selective inhibition of angiogenesis only in cancer cells. The plant extract have demonstrated 
selective inhibition of MCF-7 breast cancer cells over MCF-10A breast epithelial cells.  
Literature shows that Lipoxygenases and cyclooxygenase-2 are highly expressed in tumor 
angiogenesis (Ara &Teicher, 1996) and that successful inhibition of both these enzymes does 
inhibits tumor angiogenesis (Ye et al.2005).  We have shown that S.africana leaf extracts and 
DCM bark extracts inhibit angiogenesis through inhibition of Lipoxygenase activity in MCF-7 
cells. 
Nitric oxide has been known to induce angiogenesis and tumor metastasis, however high levels 
of nitric oxide promote apoptosis (Tschugguel et al, 1999). Therefore, nitric oxide has cancer 
promoting activity at low levels and anti-cancer activity at high levels. In our research, we 
observed that the levels of NO produced by the effect of the selected plant extracts have anti-
cancer activity. Moreover, this might be due to the ability of S. africana plant extracts in inducing 
the iNOS ( inducible-nitric oxide synthase) enzyme to produce more nitric oxide (Kumar & 




S. africana leaves had a few but essential phytochemicals that are known to have anti-
inflammatory and anti-cancer activity. The leaf extracts selectively inhibited cancer cell over 
normal cells and induced nitric oxide production in lethal concentrations. The extracts also 
inhibited COX and LOX activity in concentration dependent manner, suggesting that S. africana 
leaf extract inhibit angiogenesis in MCF-7 cells. From the bark extracts, only the DCM and 
hexane extract had the desired cytotoxic activity at an IC50 of 10 μg/ml, inducing high NO 
production and inhibited LOX activity. According to the author’s knowledge, no studies of this 
manner have been performed on this plant.    
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